Impact of systemic inflammation and autoimmune diseases on apoA-i and HDL plasma levels and functions
© The Author(s) 2015. The cholesterol of high-density lipoproteins (HDLs) and its major proteic component, apoA-I, have been widely investigated as potential predictors of acute cardiovascular (CV) events. In particular, HDL cholesterol levels were shown to be inversely and independently associated...
| Main Authors: | Montecucco, F., Favari, E., Norata, Giuseppe, Ronda, N., Nofer, J., Vuilleumier, N. |
|---|---|
| Format: | Conference Paper |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/55637 |
Similar Items
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)
by: Pirillo, A., et al.
Published: (2015)
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)
by: Remaley, A., et al.
Published: (2014)
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)
by: Catapano, A., et al.
Published: (2014)
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance
by: Borthwick, F., et al.
Published: (2012)
by: Borthwick, F., et al.
Published: (2012)
HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment
by: Garetto, S., et al.
Published: (2015)
by: Garetto, S., et al.
Published: (2015)
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
HDL and its subpopulation (HDL2 and HDL3) promote cholesterol transporters expression and attenuate inflammation in 3T3-L1 mature adipocytes induced by tumor necrosis factor-alpha
by: Suhaila Abd Muid,, et al.
Published: (2022)
by: Suhaila Abd Muid,, et al.
Published: (2022)
HDL and its subpopulation (HDL2 AND HDL3) promote cholesterol transporters expression and attenuate inflammation in 3t3-l1 mature adipocytes induced by tumor necrosis factor-alpha
by: Suhaila Abd Muid,, et al.
Published: (2022)
by: Suhaila Abd Muid,, et al.
Published: (2022)
A study of the relationship between apo E genotypes and transitions of
HDL subfractions in uncomplicated diabetes mellitus type 2, and the
effect of various anticoagulants on lipoprotein levels.
by: Rashid, Faridah Abdul
Published: (2004)
by: Rashid, Faridah Abdul
Published: (2004)
Probiotics applications in autoimmune diseases
by: Al-Salami, Hani, et al.
Published: (2012)
by: Al-Salami, Hani, et al.
Published: (2012)
Thyroid autoimmunity and autoimmune thyroid disease in Malaysian girls with Turner syndrome: an understudied population
by: Lee, Yee L, et al.
Published: (2023)
by: Lee, Yee L, et al.
Published: (2023)
Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)
by: Lam, Virginie, et al.
Published: (2011)
Autoimmune Diseases and Gut Symbionts: The Unpopular Liaison
by: Nor Effa, Zulkafli, et al.
Published: (2019)
by: Nor Effa, Zulkafli, et al.
Published: (2019)
Altered levels of serum haptoglobin and apo A-I in schizophrenia
by: Tze Jen Chow,, et al.
Published: (2011)
by: Tze Jen Chow,, et al.
Published: (2011)
Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Antinuclear antibodies in non-systemic autoimmune rheumatic
disease dermatological conditions
by: Mahayidin, Hasni, et al.
Published: (2021)
by: Mahayidin, Hasni, et al.
Published: (2021)
New tool for converting high-level representations of finite state machines to verilog HDL
by: Masoumidezfouli, Seyedhossein, et al.
Published: (2017)
by: Masoumidezfouli, Seyedhossein, et al.
Published: (2017)
APOE-E4 and APOE-491A polymorphisms in individuals with subjective memory loss
by: Laws, S., et al.
Published: (2002)
by: Laws, S., et al.
Published: (2002)
Eosinophilia in autoimmune hepatitis: is there an association?
by: Mustafa, Ahmad Suhaimi, et al.
Published: (2011)
by: Mustafa, Ahmad Suhaimi, et al.
Published: (2011)
UMP hasil HDL mampu bunuh koronavirus
by: Siti Nur Azwin, Zulkapri
Published: (2020)
by: Siti Nur Azwin, Zulkapri
Published: (2020)
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Intestinal lymphatic transport of cannabinoids: implications for people with autoimmune diseases and immunocompromised individuals
by: Zgair, Atheer
Published: (2017)
by: Zgair, Atheer
Published: (2017)
Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families
by: Kuo, Chang-Fu, et al.
Published: (2015)
by: Kuo, Chang-Fu, et al.
Published: (2015)
The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice
by: Mörk, L., et al.
Published: (2013)
by: Mörk, L., et al.
Published: (2013)
Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
by: Ammirati, E., et al.
Published: (2015)
by: Ammirati, E., et al.
Published: (2015)
Investigation of the curative effects of palm vitamin E tocotrienols on autoimmune arthritis disease in vivo
by: Zainal, Zaida, et al.
Published: (2019)
by: Zainal, Zaida, et al.
Published: (2019)
Potential impacts of Covid-19 on autoimmune diseases: a case report on Systemic Sclerosis
by: Mahayidin, Hasni, et al.
Published: (2024)
by: Mahayidin, Hasni, et al.
Published: (2024)
LOX-1 inhibition in ApoE KO mice using a schizophyllan-based antisense oligonucleotide therapy
by: Amati, F., et al.
Published: (2012)
by: Amati, F., et al.
Published: (2012)
Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019)
by: Porter, T., et al.
Published: (2019)
Analysis of the association between APOA5
polymorphism and cholesterol lowering
effects among statin users with
hypercholesterolemia from HUSM,
Kelantan
by: Tounbakjy, Mhd Houssam Iyad
Published: (2020)
by: Tounbakjy, Mhd Houssam Iyad
Published: (2020)
Alzheimer's disease detection combining novel radiogenomics of APOE e, structural and functional MRI
by: Suppiah, Subapriya, et al.
Published: (2024)
by: Suppiah, Subapriya, et al.
Published: (2024)
Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)
by: Norata, Giuseppe
Published: (2018)
Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?
by: Sharman, M., et al.
Published: (2019)
by: Sharman, M., et al.
Published: (2019)
The immuno localisation of aplipoproteins B-48 (APO B-48) and B-100 (APO B-100) in human tissues
by: Mohd Esa, Norhaizan, et al.
Published: (2001)
by: Mohd Esa, Norhaizan, et al.
Published: (2001)
Design and implementation of advanced encryption standard using verilog HDL
by: Shamsiah, Suhaili, et al.
Published: (2022)
by: Shamsiah, Suhaili, et al.
Published: (2022)
Similar Items
-
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015) -
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014) -
Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014) -
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014) -
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance
by: Borthwick, F., et al.
Published: (2012)